• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SEER 数据库的预测胰体尾癌 III/IV 期患者生存的列线图。

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.

机构信息

The First Clinical Medical College, Lanzhou University, Lanzhou, China.

School of Stomatology, Lanzhou University, Lanzhou, China.

出版信息

BMC Gastroenterol. 2022 Jun 3;22(1):279. doi: 10.1186/s12876-022-02362-2.

DOI:10.1186/s12876-022-02362-2
PMID:35658912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9164315/
Abstract

OBJECTIVE

Pancreatic body tail carcinoma (PBTC) is a relatively few pancreatic cancer in clinical practice, and its specific clinicopathological features and prognosis have not been fully described. In this study, we aimed to create a nomogram to predict the overall survival (OS) of patients with advanced PBTC.

METHODS

We extracted clinical and related prognostic data of advanced PBTC patients from 2000 to 2018 from the Surveillance, Epidemiology, and End Results database. Independent prognostic factors were selected using univariate and multivariate Cox analyses, and a nomogram was constructed using R software. The C-index, area under the curve (AUC) of receiver operating characteristic curves, calibration curves, and decision curve analysis (DCA) were used to assess the clinical utility of the nomogram. Finally, OS was assessed using the Kaplan-Meier method.

RESULTS

A total of 1256 patients with advanced PBTC were eventually included in this study. Age, grade, N stage, M stage, surgery, and chemotherapy were identified as independent risk factors using univariate and multivariate Cox regression analyses (p < 0.05). In the training cohort, the calibration index of the nomogram was 0.709, while the AUC values of the nomogram, age, grade, N stage, M stage, surgery, and chemotherapy were 0.777, 0.562, 0.621, 0.5, 0.576, 0.632, and 0.323, respectively. Meanwhile, in the validation cohort, the AUC values of the nomogram, age, grade, N stage, M stage, surgery, and chemotherapy were 0.772, 0.551, 0.629, 0.534, 0.577, 0.606, and 0.639, respectively. Good agreement of the model in the training and validation cohorts was demonstrated in the calibration and DCA curves. Univariate survival analysis showed a statistically significant effect of age, grade, M stage, and surgery on prognosis (p < 0.05).

CONCLUSION

Age, grade, M stage, and surgery were independently associated with OS, and the established nomogram was a visual tool to effectively predict OS in advanced PBTC patients.

摘要

目的

胰腺体尾部癌(PBTC)是临床实践中相对较少见的胰腺癌,其具体的临床病理特征和预后尚未得到充分描述。本研究旨在建立一个列线图来预测晚期 PBTC 患者的总生存期(OS)。

方法

我们从 2000 年至 2018 年从监测、流行病学和最终结果(SEER)数据库中提取晚期 PBTC 患者的临床和相关预后数据。使用单因素和多因素 Cox 分析选择独立的预后因素,并使用 R 软件构建列线图。C 指数、接收者操作特征曲线(ROC)下面积(AUC)、校准曲线和决策曲线分析(DCA)用于评估列线图的临床实用性。最后,使用 Kaplan-Meier 方法评估 OS。

结果

本研究最终纳入了 1256 名晚期 PBTC 患者。单因素和多因素 Cox 回归分析显示,年龄、分级、N 分期、M 分期、手术和化疗是独立的危险因素(p<0.05)。在训练队列中,列线图的校准指数为 0.709,而列线图、年龄、分级、N 分期、M 分期、手术和化疗的 AUC 值分别为 0.777、0.562、0.621、0.5、0.576、0.632 和 0.323。同时,在验证队列中,列线图、年龄、分级、N 分期、M 分期、手术和化疗的 AUC 值分别为 0.772、0.551、0.629、0.534、0.577、0.606 和 0.639。校准和 DCA 曲线表明,模型在训练和验证队列中的一致性良好。单因素生存分析显示,年龄、分级、M 分期和手术对预后有统计学意义(p<0.05)。

结论

年龄、分级、M 分期和手术与 OS 独立相关,建立的列线图是有效预测晚期 PBTC 患者 OS 的可视化工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/ef3da29a8854/12876_2022_2362_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/b32faeb16a70/12876_2022_2362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/00d90e90fc60/12876_2022_2362_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/c7697539b280/12876_2022_2362_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/e65be27a9061/12876_2022_2362_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/ef3da29a8854/12876_2022_2362_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/b32faeb16a70/12876_2022_2362_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/00d90e90fc60/12876_2022_2362_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/c7697539b280/12876_2022_2362_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/e65be27a9061/12876_2022_2362_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c8/9164315/ef3da29a8854/12876_2022_2362_Fig5_HTML.jpg

相似文献

1
A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.基于 SEER 数据库的预测胰体尾癌 III/IV 期患者生存的列线图。
BMC Gastroenterol. 2022 Jun 3;22(1):279. doi: 10.1186/s12876-022-02362-2.
2
The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.基于 SEER 数据库和中国队列研究的列线图预测胰腺癌患者放疗后总生存的研究。
Front Endocrinol (Lausanne). 2023 Oct 25;14:1266318. doi: 10.3389/fendo.2023.1266318. eCollection 2023.
3
A nomogram for predicting survival in Patients with oral tongue keratinized squamous cell carcinoma: A SEER-based study.基于 SEER 数据库的预测口腔舌部角化鳞状细胞癌患者生存的列线图。
J Stomatol Oral Maxillofac Surg. 2023 Sep;124(4):101422. doi: 10.1016/j.jormas.2023.101422. Epub 2023 Feb 11.
4
Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.列线图预测胰腺癌骨转移的风险和预后因素:基于人群的分析。
Front Endocrinol (Lausanne). 2022 Mar 9;12:752176. doi: 10.3389/fendo.2021.752176. eCollection 2021.
5
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
6
Construction and application of dynamic online nomogram for prognosis prediction of patients with advanced (Stage III/IV) tongue squamous cell carcinoma.构建并应用动态在线列线图预测晚期(Ⅲ/Ⅳ期)舌鳞癌患者的预后。
J Stomatol Oral Maxillofac Surg. 2023 Oct;124(5):101477. doi: 10.1016/j.jormas.2023.101477. Epub 2023 Apr 18.
7
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
8
Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.化疗治疗小细胞肺癌患者总生存预后列线图:基于 SEER 的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):346-359. doi: 10.1007/s12325-021-01974-6. Epub 2021 Nov 3.
9
Construction of webbased prediction nomogram models for cancerspecific survival in patients at stage IV of hepatocellular carcinoma depending on SEER database.基于监测、流行病学和最终结果(SEER)数据库构建用于预测肝细胞癌IV期患者癌症特异性生存的网络预测列线图模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1546-1560. doi: 10.11817/j.issn.1672-7347.2023.230040.
10
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.

引用本文的文献

1
Development and validation of machine learning nomograms for predicting survival in stage IV pancreatic cancer: A retrospective study.用于预测IV期胰腺癌生存率的机器学习列线图的开发与验证:一项回顾性研究。
World J Gastrointest Oncol. 2025 May 15;17(5):102459. doi: 10.4251/wjgo.v17.i5.102459.
2
Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology.基于全基因组DNA甲基化测序技术鉴定预测胰腺癌患者预后的甲基化驱动基因。
Heliyon. 2024 Apr 22;10(9):e29914. doi: 10.1016/j.heliyon.2024.e29914. eCollection 2024 May 15.
3

本文引用的文献

1
Editorial for "MRI Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study".《基于MRI影像组学的列线图预测胰腺导管腺癌胰周淋巴结转移的多中心研究》编者按
J Magn Reson Imaging. 2022 Mar;55(3):840-841. doi: 10.1002/jmri.28090. Epub 2022 Feb 1.
2
A novel immune-related gene signature predicting survival in sarcoma patients.一种预测肉瘤患者生存情况的新型免疫相关基因特征。
Mol Ther Oncolytics. 2021 Dec 9;24:114-126. doi: 10.1016/j.omto.2021.12.007. eCollection 2022 Mar 17.
3
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030.
全球 1990 年至 2019 年归因于代谢风险的胰腺癌负担,以及对 2030 年死亡率的预测。
BMC Public Health. 2024 Feb 13;24(1):456. doi: 10.1186/s12889-024-17875-6.
4
Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044.1990 年至 2019 年西太平洋地区胰腺癌死亡率的时间趋势:年龄-时期-队列分析及 2044 年预测。
BMC Cancer. 2023 Sep 18;23(1):876. doi: 10.1186/s12885-023-11369-1.
5
Can a CT-based nomogram predict recurrence in resectable pancreatic body and tail adenocarcinoma?基于CT的列线图能否预测可切除胰体尾腺癌的复发?
Eur Radiol. 2023 Nov;33(11):7779-7781. doi: 10.1007/s00330-023-10193-2. Epub 2023 Sep 6.
6
A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy.基于 CT 纹理特征的列线图预测接受化疗的晚期胰腺癌患者的反应。
BMC Gastroenterol. 2023 Aug 10;23(1):274. doi: 10.1186/s12876-023-02902-4.
7
Prognostic Predicting Model of Pancreatic Body Tail Carcinoma Using Clinical and CT Radiomic Data.基于临床和 CT 影像组学数据的胰腺体尾部癌预后预测模型。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231186739. doi: 10.1177/15330338231186739.
8
Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer.用于预测可切除胰腺癌术前淋巴结转移的列线图。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12469-12477. doi: 10.1007/s00432-023-05048-8. Epub 2023 Jul 14.
基于饮食和生活方式的预测模型估算 III 期结肠癌患者的癌症复发和死亡(CALGB 89803/Alliance)。
J Clin Oncol. 2022 Mar 1;40(7):740-751. doi: 10.1200/JCO.21.01784. Epub 2022 Jan 7.
4
[Trend analysis on morbidity and mortality of pancreatic cancer in China, 2005-2015].[2005 - 2015年中国胰腺癌发病与死亡趋势分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 May 10;42(5):794-800. doi: 10.3760/cma.j.cn112338-20201115-01328.
5
Pancreatic cancer in 2021: What you need to know to win.2021 年胰腺癌:赢得胜利需要了解的知识。
World J Gastroenterol. 2021 Sep 21;27(35):5851-5889. doi: 10.3748/wjg.v27.i35.5851.
6
Minimally Invasive Versus Open Radical Antegrade Modular Pancreatosplenectomy: A Meta-Analysis.微创与开放根治性顺行模块化胰脾切除术:一项荟萃分析。
World J Surg. 2022 Jan;46(1):235-245. doi: 10.1007/s00268-021-06328-5. Epub 2021 Oct 5.
7
ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial.ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial.
Trials. 2021 Sep 16;22(1):633. doi: 10.1186/s13063-021-05523-y.
8
Clinical dilemma of endoscopic ultrasound-guided fine needle aspiration for resectable pancreatic body and tail cancer.内镜超声引导下细针抽吸用于可切除胰体尾癌的临床困境。
Dig Endosc. 2022 Jan;34(2):307-316. doi: 10.1111/den.14120. Epub 2021 Sep 24.
9
Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.基于 SEER 数据库的肺转移性肾细胞癌患者预后列线图模型研究。
Ann Palliat Med. 2021 Mar;10(3):2791-2804. doi: 10.21037/apm-20-1488. Epub 2021 Feb 7.
10
Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature.单纯黏液性囊腺瘤:胰腺中另一种潜在的癌前病变?病例报告并结合文献系统回顾
Virchows Arch. 2021 Jul;479(1):179-189. doi: 10.1007/s00428-021-03029-1. Epub 2021 Jan 28.